Titre:
  • Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): A randomized phase II trial
Auteur:Ignatiadis, Michail; Litieère, S.; Rothé, Françoise; Riethdorf, Sabine; Proudhon, Charlotte; Fehm, Tanja Natascha T.; Aalders, Kim K.C.; Forstbauer, Helmut; Fasching, Peter Andreas; Brain, Etienne; Vuylsteke, Peter; Guardiola, Emmanuel; Lorenz, Ralf; Pantel, Klaus; Tryfonidis, Konstantinos; Janni, Wolfgang; Piccart-Gebhart, Martine; Sotiriou, Christos; Rack, Brigitte; Pierga, Jean Yves Ves J.Y.
Informations sur la publication:Annals of oncology, 29, 8, page (1777-1783)
Statut de publication:Publié, 2018
Sujet CREF:Cancérologie
Hématologie
Mots-clés:Breast cancer
Circulating tumor cells
Liquid biopsy
Trastuzumab
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdy211
info:scp/85055050791